“The current scenario has exposed some structural weaknesses within the EU’s medicines offer chain in addition to a superior dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides explained. She advised that supply chain difficulties be dealt with within an EU pharmaceutical approach envisioned being … Read More